EGFR and non-small cell lung carcinoma: Additionally, we reported here that the ability to establish PDXs was a strong marker of poor prognosis for both OS and PSF in NSCLC, which is consistent with the results from EGFR-mutant NSCLC PDXs (Stewart et al. 2015).